Published in J Pharm Pharmacol on March 01, 2011
Secretory leucoprotease inhibitor binds to NF-kappaB binding sites in monocytes and inhibits p65 binding. J Exp Med (2005) 1.65
Targeted liposomal drug delivery to monocytes and macrophages. J Drug Deliv (2010) 1.08
Inhalable siRNA: potential as a therapeutic agent in the lungs. Mol Pharm (2008) 1.07
A comparative study of a range of polymeric microspheres as potential carriers for the inhalation of proteins. Int J Pharm (2008) 0.99
Chitosan for gene delivery and orthopedic tissue engineering applications. Molecules (2013) 0.88
Delivery of rSLPI in a liposomal carrier for inhalation provides protection against cathepsin L degradation. J Microencapsul (2009) 0.85
High levels of ephrinB2 over-expression increases the osteogenic differentiation of human mesenchymal stem cells and promotes enhanced cell mediated mineralisation in a polyethyleneimine-ephrinB2 gene-activated matrix. J Control Release (2012) 0.85
The development of non-viral gene-activated matrices for bone regeneration using polyethyleneimine (PEI) and collagen-based scaffolds. J Control Release (2011) 0.84
Combinatorial gene therapy accelerates bone regeneration: non-viral dual delivery of VEGF and BMP2 in a collagen-nanohydroxyapatite scaffold. Adv Healthc Mater (2014) 0.84
The effects of excipients and particle engineering on the biophysical stability and aerosol performance of parathyroid hormone (1-34) prepared as a dry powder for inhalation. AAPS PharmSciTech (2011) 0.82
In vitro activities of synthetic host defense propeptides processed by neutrophil elastase against cystic fibrosis pathogens. Antimicrob Agents Chemother (2011) 0.81
Non-viral gene-activated matrices: next generation constructs for bone repair. Organogenesis (2013) 0.79
Therapeutic aerosol bioengineering of siRNA for the treatment of inflammatory lung disease by TNFα gene silencing in macrophages. Mol Pharm (2014) 0.79
Targeting miRNA-based medicines to cystic fibrosis airway epithelial cells using nanotechnology. Int J Nanomedicine (2013) 0.78
Screening of siRNA nanoparticles for delivery to airway epithelial cells using high-content analysis. Ther Deliv (2011) 0.78
'Smart' non-viral delivery systems for targeted delivery of RNAi to the lungs. Ther Deliv (2013) 0.77
The application of high-content analysis in the study of targeted particulate delivery systems for intracellular drug delivery to alveolar macrophages. Mol Pharm (2011) 0.76
A dry powder formulation of liposome-encapsulated recombinant secretory leukocyte protease inhibitor (rSLPI) for inhalation: preparation and characterisation. AAPS PharmSciTech (2010) 0.76
The effect of liposome encapsulation on the pharmacokinetics of recombinant secretory leukocyte protease inhibitor (rSLPI) therapy after local delivery to a guinea pig asthma model. Pharm Res (2011) 0.75